Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide conversion--a potential pathway modulating G-protein signaling.

F Nyberg1, M Hallberg

  • 1Department of Pharmaceutical Biosciences, Division of Biological Research on Drug Dependence, Uppsala University, P.O. Box 591, S-751 24 UPPSALA, Sweden. Fred.Nyberg@farmbio.uu.se

Current Drug Targets
|February 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.

Vaccine·2022
Same author

The Swedish National Airway Register (SNAR): development, design and utility to date.

European clinical respiratory journal·2020
Same author

Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A.

The British journal of dermatology·2019
Same author

Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.

The British journal of dermatology·2019
Same author

Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.

The British journal of dermatology·2019
Same author

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).

Journal of the European Academy of Dermatology and Venereology : JEADV·2016

Neuropeptides can be broken down into bioactive fragments that modulate their original effects. These fragments, derived from opioid peptides, substance P, and angiotensin II, can mimic or counteract parent peptide actions.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Biochemistry

Background:

  • Neuropeptides act via G-protein coupled receptors on cell surfaces.
  • Receptor activation leads to cellular effects and subsequent peptide degradation.
  • Enzymatic conversion of neuropeptides can yield bioactive fragments.

Purpose of the Study:

  • To review the phenomenon of bioactive peptide fragment generation.
  • To focus on fragments from opioid peptides, substance P, and angiotensin II.
  • To explore how these fragments modulate parent peptide actions.

Main Methods:

  • Literature review of neuropeptide systems.
  • Analysis of enzymatic conversion pathways.
  • Examination of fragment-receptor interactions.

Related Experiment Videos

Main Results:

  • Bioactive fragments can mimic or counteract parent peptide effects.
  • Fragments may interact with the same or distinct receptors.
  • Modulatory roles identified in opioid, tachykinin, and renin-angiotensin systems.

Conclusions:

  • Enzymatic conversion generates bioactive fragments that modulate neuropeptide signaling.
  • These fragments play a significant role in fine-tuning cellular responses.
  • Understanding fragment activity is crucial for comprehending peptide system regulation.